Grown Rogue International (GRUSF) Depreciation & Amortization (CF) (2025 - 2026)

Grown Rogue International (GRUSF) recorded quarterly Depreciation & Amortization (CF) of $91162.0 in Q1 2026, down 13.17% quarter-over-quarter from $104984.0 in Q1 2025, and down 13.17% on a YoY basis from $104984.0 in Q1 2025.

Grown Rogue International (GRUSF) Depreciation & Amortization (CF) (2025 - 2026) Analysis & Trends

Grown Rogue International's Depreciation & Amortization (CF) history runs 2 years deep, the most recent figure standing at $91162.0 for Q1 2026.

  • In Q1 2026, Depreciation & Amortization (CF) fell 13.17% year-over-year to $91162.0; the TTM figure through Mar 2026 stood at $91162.0 (down 13.17% YoY), while the FY2025 annual figure was $702258.0, down 29.31% from the prior year.
  • Depreciation & Amortization (CF) was $91162.0 for Q1 2026 at Grown Rogue International, down from $104984.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $104984.0 in Q1 2025 to a low of $91162.0 in Q1 2026.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 239.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 119.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 22.60 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 7.20 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 172.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 19.43 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 21.95 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 22.68 Mn
10 Grown Rogue International - - 3.96 Mn 91,162.00

Historic Data

Download Data
DateValue
Mar 31, 2026 91,162.00
Mar 31, 2026 91,162.00
Mar 31, 2025 104,984.00
Mar 31, 2025 104,984.00